Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Taro Kishi,1 Yuki Matsuda,1 Shinji Matsunaga,1 Masatsugu Moriwaki,1,2 Yoichiro Otake,2 Kaku Akamatsu,3 Tomo Okochi,4 Shigeki Hirano,4 Toshihiko Funahashi,5 Momoko Okuda,6 Hideaki Tabuse,6 Kiyoshi Fujita,2 Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, 2Departmen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Format:	article
Language:	EN
Published:	Dove Medical Press 2017
Subjects:	escitalopram paroxetine controlled release major depressive disorder Hamilton Rating Scale for Depression antidepressant Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Online Access:	https://doaj.org/article/e08792372efe44ce84e76d859348dd3c
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Similar Items